Prognosis of pediatric hepatic Wilson disease with ATP7B loss of function variants
Open Access
- 15 August 2026
- journal article
- Published by Korean Pediatric Society in Clinical and Experimental Pediatrics
- Vol. 69 (8) , 646-654
Abstract
Background: Genotype-phenotype correlations in Wilson disease (WD) have so far been inconclusive.Purpose: ATP7B variants with loss of function (LOF) may have a different trajectory. Since genotypes in Asia differ from the West, we aimed to correlate LOF variants of ATP7B with the severity and outcome of hepatic WD.Methods: Patients with a confirmed diagnosis of WD (Leipzig criteria ≥4) were prospectively enrolled. Genetic sequencing of ATP7Bmutations was assessed by Whole-exome sequencing. For patients with variants of uncertain significance, Sanger sequencing was additionally performed on their parents to identify the inherited variants. In silico analyses were used to predict the pathogenicity of variants. Mutations that resulted in at least one truncation (nonsense, frameshift, splice site, deletions) and nontruncation (missense, synonymous) protein were defined as LOF and no LOF (NLF) respectively. Phenotypes, biochemical parameters, and outcomes were analyzed.Results: One hundred sixteen hepatic WD children (84 boys, median age at diagnosis 8.9±3.3 years) with biallelic ATP7B mutations (62 different variants) were enrolled. The most common LOF (n=79) and NLF (n=37) variants were c.813C>A and c.3809A>G. Advanced liver disease (76% vs. 4%, P=0.004), portal hypertension (44% vs. 24%, P=0.03), neurological (39% vs. 16%, P=0.01) and renal involvement (44% vs. 13%, P=0.01) were significantly higher in LOF than in NLF. c.813C>A had higher serum exchangeable copper (6.8±4.4 μmol/L vs. 1.4±3.5 μmol/L, P=0.04) and lower disappearance of the Kayser-Fleischer ring (4% vs. 49%, P= 0.01) than c.3809A>G variants. Over a follow-up of 6.1±4.7 years, a single LOF variant did not show a poorer liver or overall outcomes in comparison to ≥2 LOF variants.Conclusion: A single ATP7B LOF variant, especially c.813C>A was associated with advanced liver disease, portal hypertension, and extrahepatic involvement. LOF variants did not affect liver or overall outcomes.Keywords
Funding Information
- Department of Health Research, Indian Council of Medical Research, New Delhi (R. 11014/50/2023-GIA/HR)
This publication has 27 references indexed in Scilit:
- Nuances in ATP7B Genetic Testing and Interpretation in IndiaJournal of Clinical and Experimental Hepatology, 2025
- The Genomic Landscape of Wilson Disease in a Pan India Disease Cohort and Population‐Scale DataMovement Disorders Clinical Practice, 2024
- Copper exposure induces mitochondrial dysfunction and hepatotoxicity via the induction of oxidative stress and PERK/ATF4 -mediated endoplasmic reticulum stressEnvironmental Pollution, 2024
- ATP7B Genotype and Chronic Liver Disease Treatment Outcomes in Wilson Disease: Worse Survival With Loss-of-Function VariantsClinical Gastroenterology and Hepatology, 2022
- Effect of chelation therapy in pediatric Wilson’s disease: Liver and endoscopic outcomeJournal of Hepato-Biliary-Pancreatic Sciences, 2020
- Age and Sex but Not ATP7B Genotype Effectively Influence the Clinical Phenotype of Wilson DiseaseHepatology, 2018
- EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosisJournal of Hepatology, 2018
- Concordance rates of Wilson's disease phenotype among siblingsJournal of Inherited Metabolic Disease, 2013
- Genotype–phenotype correlation in Italian children with Wilson’s diseaseJournal of Hepatology, 2009
- Genotype–phenotype correlations for a wide spectrum of mutations in the Wilson disease gene (ATP7B)American Journal of Medical Genetics Part A, 2004